Table 2 Predictors of progression-free survival.

From: The heavy chain of 4F2 antigen promote prostate cancer progression via SKP-2

 

Univariate analysis

Multivariate analysis

Cut off

HR

95% CI

P

HR

95% CI

P

 

Age (y)

66

0.96

0.37–2.43

0.9281

    

cT stage

2

4.86

1.84–14.16

0.0014

4.22

1.64–18.73

0.0280

*

GS

7

3.06

1.00–13.25

0.0488

1.78

0.24–36.35

0.6028

 

TST (ng/dL)

4.64

0.69

0.26–1.76

0.4364

    

PSA (ng/mL)

7.90

1.74

0.70–4.51

0.2284

    

4F2hc Score

High/Low

4.59

1.65–16.25

0.0027

11.54

1.16–276.67

0.0357

*

LAT1 Score

High/Low

2.68

0.87–11.64

0.0886

    

SKP2 Score

High/Low

6.92

1.83–45.07

0.0029

0.73

0.14–6.99

0.7534

 
  1. HR = Cox proportional hazard ratio, 95% CI = 95% confidence interval, cT stage = clinical tumour stage, GS = Gleason score, TST = testosterone, PSA = prostate-specific antigen.
  2. *Statistical significance (p < 0.05).
Back to article page